The gene encoding fibroblast growth factor receptor 1 (FGFR1) is emerging as a therapeutic and prognostic biomarker in various cancer types, including head and neck squamous cell carcinoma (SCC). The gene discussed is FGFR1; the disease is head and neck squamous cell carcinoma.